IP Library Granted Patent US 12,485,256
Granted Patent B2
US 12,485,256 · App. 18/192,948 · Granted Dec 2, 2025

Systems and methods for endovascularly accessing a subarachnoid space

Inventors: Adel M. Malek (Weston, MA); Carl Heilman (Wayland, MA); David A. Rezac (Westborough, MA); Jack B. Sattell (Boston, MA); Anthony Maiorano (Jamaica Plain, MA)
Assignee: Cerevasc, Inc.
A61M27/006A61M25/04A61B2017/00252A61B2017/22077A61B17/3478A61F2/915A61M25/0147A61M25/065A61M25/09A61M2202/0464A61M2205/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,485,256
App. No.
18/192,948
Granted
Dec 2, 2025
Kind
B2
Abstract

Systems and methods for implanting an endovascular shunt in a patient is disclosed. The system having an expandable anchor configured for being deployed in a dural venous sinus of a patient at a location distal to a curved portion of a wall of an inferior petrosal sinus (IPS) of the patient; an elongate guide member coupled to, and extending proximally from, the anchor; a shunt delivery catheter having a first lumen configured to receive the guide member, and a second lumen extending between respective proximal and distal openings in the shunt delivery catheter, the shunt delivery catheter further having a penetrating element coupled to a distal end of the catheter; and the system further having a guard at least partially disposed over, and movable relative to, the penetrating element.

Claims (21)

1 . A system for endovascularly accessing a subarachnoid space (SAS) in a patient, the system comprising:

an expandable anchor configured for being deployed in a dural venous sinus of a patient at a location distal to a curved portion of a sinus wall of the patient;

an elongate guide member coupled to, and extending proximally from, the anchor;

an SAS access catheter comprising a first lumen extending between respective proximal and distal openings in the SAS access catheter, a penetrating element coupled to a distal end of the SAS access catheter; and

a guard at least partially disposed over, and movable relative to, the penetrating element, wherein the guard comprises a tubular guard body having a first guard body lumen or recess configured to receive the penetrating element, a second guard body lumen configured to accommodate passage therethrough of the guide member, and a pull wire having a distal portion attached to the guard body, wherein the pull wire is configured to translate the guard body proximally relative to the SAS access catheter so as to at least partially expose the penetrating element.

2 . The endovascular SAS access system of claim 1 , wherein the pull wire is configured to translate the guard body distally relative to the SAS access catheter so as to at least partially cover the penetrating element.

3 . The endovascular SAS access system of claim 1 , wherein the SAS access catheter further comprises a second lumen extending from the proximal opening to the distal portion of the SAS access catheter, wherein the second lumen is configured to receive the pull wire.

4 . The endovascular SAS access system of claim 1 , wherein a distal portion of the guard body is beveled or tapered.

5 . The endovascular SAS access system of claim 1 , further comprising a first radiopaque marker disposed in or on a wall of the guard body, wherein the guard body is movable relative to the penetrating element so that the first radiopaque marker may be positioned so as to at least partially overlie the penetrating element.

6 . The endovascular SAS access system of claim 5 , wherein the pull wire is coupled to the first radiopaque marker.

7 . The endovascular SAS access system of claim 6 , further comprising a second radiopaque marker disposed in or on the distal portion of the SAS access catheter, wherein the guard body is movable relative to the SAS access catheter so that the first radiopaque marker at least partially overlies the second radiopaque marker.

8 . The endovascular SAS access system of claim 1 , wherein the sinus wall comprises an inferior petrosal sinus of the patient.

9 . The endovascular SAS access system of claim 1 , wherein the dural venous sinus comprises an inferior petrosal sinus or cavernous sinus of the patient.

10 . The endovascular SAS access implantation system claim 1 , further comprising an anchor pusher configured for translating the anchor through an anchor delivery catheter for deployment in the dural venous sinus.

11 . The endovascular SAS access system of claim 10 , wherein the anchor pusher comprises a handle having a lumen extending therethrough; and a hypo tube coupled to the handle, the hypo tube having a hypo tube lumen that is contiguous with or otherwise extends through the handle lumen, the respective handle and hypo tube lumens being configured to receive the guide member, wherein the handle is configured to grasp a portion of the guide member extending proximally through the handle lumen for thereby pushing the guide member, and thus the anchor, distally through the anchor delivery catheter.

12 . The endovascular SAS access system of claim 1 , further comprising a shunt disposed in the first lumen of the delivery catheter.

13 . The endovascular SAS access system of claim 12 , further comprising a pusher member configured to deliver the shunt through the respective first lumen and distal opening of the SAS access catheter.

14 . The endovascular SAS access system of claim 12 , wherein a distal portion of the shunt comprises one or more cerebrospinal fluid (CSF) intake openings disposed in a distal portion of the shunt, the shunt further comprising a valve disposed proximally of the one or more CSF intake openings, and a lumen extending between the one or more CSF intake openings and the valve.

15 . The endovascular SAS access system of claim 14 , wherein the valve is configured to regulate CSF flow through the shunt at a rate of approximately 10 milliliters per hour at a normal differential pressure between the SAS and a venous system of the patient.

16 . The endovascular SAS access system of claim 15 , wherein the valve is a one-way valve configured resist blood backflow through the shunt.

17 . The endovascular SAS access system of claim 1 , wherein the expandable anchor is a self-expanding stent.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2023
From: HEILMAN, CARL; MALEK, ADEL M.; REZAC, DAVID A.; SATTELL, JACK B.; MAIORANO, ANTHONY A.
To: CEREVASC, LLC
Reel/Frame 063166/0123 →
CHANGE OF NAME Recorded Mar 30, 2023
From: CEREVASC, LLC
To: CEREVASC, INC.
Reel/Frame 063196/0930 →
Continuity (9)
Continuation 16986245 · Aug 5, 2020
Continuation 15981497 · May 16, 2018
Continuation 15745961
Provisional Application 62406825 · Oct 11, 2016
Provisional Application 62332444 · May 5, 2016
Provisional Application 62301523 · Feb 29, 2016
Provisional Application 62290384 · Feb 2, 2016
Provisional Application 62249145 · Oct 30, 2015
Related Publication 20230233820A1 · Jul 27, 2023
References Cited (340)
US 575997A · Spencer · 1897 [cited by applicant]
US 3492996A · Fountain · 1970 [cited by applicant]
US 3894541A · El-Shafei · 1975 [cited by applicant]
US 4413985A · Wellner et al. · 1983 [cited by applicant]
US 4474569A · Newkirk · 1984 [cited by applicant]
US 4475898A · Brodner et al. · 1984 [cited by applicant]
US 4631051A · Harris · 1986 [cited by applicant]
US 4737153A · Shimamura et al. · 1988 [cited by applicant]
US 4950232A · Ruzicka et al. · 1990 [cited by applicant]
US 5000731A · Wong et al. · 1991 [cited by applicant]
US 5137288A · Starkey et al. · 1992 [cited by applicant]
US 5160325A · Nichols et al. · 1992 [cited by applicant]
US 5193546A · Shaknovich · 1993 [cited by applicant]
US 5221261A · Termin et al. · 1993 [cited by applicant]
US 5385541A · Kirsch et al. · 1995 [cited by applicant]
US 5405316A · Magram · 1995 [cited by applicant]
US 5496329A · Reisinger · 1996 [cited by applicant]
US 5562641A · Flomenblit et al. · 1996 [cited by applicant]
US 5634475A · Wolvek · 1997 [cited by applicant]
US 5725571A · Imbert et al. · 1998 [cited by applicant]
US 5725572A · Lam et al. · 1998 [cited by applicant]
US 5746725A · Shalon et al. · 1998 [cited by applicant]
US 5792157A · Mische et al. · 1998 [cited by applicant]
US 5800520A · Fogarty et al. · 1998 [cited by applicant]
US 5830222A · Makower · 1998 [cited by applicant]
US 5851199A · Peerless et al. · 1998 [cited by applicant]
US 5885258A · Sachdeva et al. · 1999 [cited by applicant]
US 5976131A · Guglielmi et al. · 1999 [cited by applicant]
US 5984929A · Bashiri et al. · 1999 [cited by applicant]
US 6015405A · Schwartz et al. · 2000 [cited by applicant]
US 6066158A · Engelson et al. · 2000 [cited by applicant]
US 6068638A · Makower · 2000 [cited by applicant]
US 6071292A · Makower et al. · 2000 [cited by applicant]
US 6093199A · Brown et al. · 2000 [cited by applicant]
US 6096053A · Bates · 2000 [cited by applicant]
US 6126628A · Nissels · 2000 [cited by applicant]
US 6126649A · VanTassel et al. · 2000 [cited by applicant]
US 6126672A · Berryman et al. · 2000 [cited by applicant]
US 6159225A · Makower · 2000 [cited by applicant]
US 6186972B1 · Nelson et al. · 2001 [cited by applicant]
US 6190353B1 · Makower et al. · 2001 [cited by applicant]
US 6231587B1 · Makower · 2001 [cited by applicant]
US 6283934B1 · Borgeson · 2001 [cited by applicant]
US 6283951B1 · Flaherty et al. · 2001 [cited by applicant]
US 6283983B1 · Makower et al. · 2001 [cited by applicant]
US 6287317B1 · Makower et al. · 2001 [cited by applicant]
US 6302875B1 · Makower et al. · 2001 [cited by applicant]
US 6330884B1 · Kim · 2001 [cited by applicant]
US 6350271B1 · Kurz et al. · 2002 [cited by applicant]
US 6375615B1 · Flaherty et al. · 2002 [cited by applicant]
US 6379319B1 · Garibotto et al. · 2002 [cited by applicant]
US 6402771B1 · Palmer et al. · 2002 [cited by applicant]
US 6425909B1 · Dieck et al. · 2002 [cited by applicant]
US 6432127B1 · Kim et al. · 2002 [cited by applicant]
US 6491707B2 · Makower et al. · 2002 [cited by applicant]
US 6508824B1 · Flaherty et al. · 2003 [cited by applicant]
US 6527790B2 · Chien et al. · 2003 [cited by applicant]
US 6530935B2 · Wensel et al. · 2003 [cited by applicant]
US 6544230B1 · Flaherty et al. · 2003 [cited by applicant]
US 6561998B1 · Roth et al. · 2003 [cited by applicant]
US 6569145B1 · Shmulewitz et al. · 2003 [cited by applicant]
US 6575997B1 · Palmer et al. · 2003 [cited by applicant]
US 6579302B2 · Duerig et al. · 2003 [cited by applicant]
US 6579311B1 · Makower · 2003 [cited by applicant]
US 6589164B1 · Flaherty · 2003 [cited by applicant]
US 6602241B2 · Makower et al. · 2003 [cited by applicant]
US 6613081B2 · Kim et al. · 2003 [cited by applicant]
US 6616675B1 · Evard et al. · 2003 [cited by applicant]
US 6638293B1 · Makower et al. · 2003 [cited by applicant]
US 6655386B1 · Makower et al. · 2003 [cited by applicant]
US 6660021B1 · Palmer et al. · 2003 [cited by applicant]
US 6660024B1 · Flaherty et al. · 2003 [cited by applicant]
US 6663650B2 · Sepetka et al. · 2003 [cited by applicant]
US 6685648B2 · Flaherty et al. · 2004 [cited by applicant]
US 6685716B1 · Flaherty et al. · 2004 [cited by applicant]
US 6709444B1 · Makower · 2004 [cited by applicant]
US 6716238B2 · Elliott · 2004 [cited by applicant]
US 6719750B2 · Varner et al. · 2004 [cited by applicant]
US 6726677B1 · Flaherty et al. · 2004 [cited by applicant]
US 6730104B1 · Sepetka et al. · 2004 [cited by applicant]
US 6746426B1 · Flaherty et al. · 2004 [cited by applicant]
US 6746464B1 · Makower · 2004 [cited by applicant]
US 6863684B2 · Kim et al. · 2005 [cited by applicant]
US 7056325B1 · Makower et al. · 2006 [cited by applicant]
US 7083588B1 · Shmulewitz et al. · 2006 [cited by applicant]
US 7094230B2 · Flaherty et al. · 2006 [cited by applicant]
US 7134438B2 · Makower et al. · 2006 [cited by applicant]
US 7172571B2 · Moskowitz et al. · 2007 [cited by applicant]
US 7179270B2 · Makower · 2007 [cited by applicant]
US 7191015B2 · Lamson et al. · 2007 [cited by applicant]
US 7300458B2 · Henkes et al. · 2007 [cited by applicant]
US 7303571B2 · Makower et al. · 2007 [cited by applicant]
US 7316655B2 · Garibotto et al. · 2008 [cited by applicant]
US 7316692B2 · Huffmaster · 2008 [cited by applicant]
US 7357794B2 · Makower et al. · 2008 [cited by applicant]
US 7407506B2 · Makower · 2008 [cited by applicant]
US 7606615B2 · Makower et al. · 2009 [cited by applicant]
US 7621950B1 · Globernnan · 2009 [cited by applicant]
US 7637870B2 · Flaherty et al. · 2009 [cited by applicant]
US 7648517B2 · Makower et al. · 2010 [cited by applicant]
US 7670329B2 · Flaherty et al. · 2010 [cited by applicant]
US 7729738B2 · Flaherty et al. · 2010 [cited by applicant]
US 7797053B2 · Atkinson et al. · 2010 [cited by applicant]
US 7846172B2 · Makower · 2010 [cited by applicant]
US 7955343B2 · Makower et al. · 2011 [cited by applicant]
US 7966057B2 · Macaulay et al. · 2011 [cited by applicant]
US 7989042B2 · Obara et al. · 2011 [cited by applicant]
US 8075580B2 · Makower · 2011 [cited by applicant]
US 8083708B2 · Flaherty et al. · 2011 [cited by applicant]
US 8088140B2 · Ferrera et al. · 2012 [cited by applicant]
US 8090430B2 · Makower et al. · 2012 [cited by applicant]
US 8118827B2 · Duerig · 2012 [cited by applicant]
US 8214015B2 · Macaulay et al. · 2012 [cited by applicant]
US 8292950B2 · Dorn et al. · 2012 [cited by applicant]
US 8295947B2 · Lamson et al. · 2012 [cited by applicant]
US 8317748B2 · Fiorella et al. · 2012 [cited by applicant]
US 8486104B2 · Samson et al. · 2013 [cited by applicant]
US 8540759B2 · Porter · 2013 [cited by applicant]
US 8585596B1 · Flaherty et al. · 2013 [cited by applicant]
US 8672871B2 · Heilman et al. · 2014 [cited by applicant]
US 8672920B2 · Makower et al. · 2014 [cited by applicant]
US 8715314B1 · Janardhan et al. · 2014 [cited by applicant]
US 8727988B2 · Flaherty et al. · 2014 [cited by applicant]
US 8740833B2 · Moskowitz et al. · 2014 [cited by applicant]
US 8753366B2 · Makower et al. · 2014 [cited by applicant]
US 8795317B2 · Grandfield et al. · 2014 [cited by applicant]
US 8852205B2 · Brady et al. · 2014 [cited by applicant]
US 8876792B2 · Holmin et al. · 2014 [cited by applicant]
US 8926680B2 · Ferrera et al. · 2015 [cited by applicant]
US 8974513B2 · Ford et al. · 2015 [cited by applicant]
US 8992456B1 · Powell · 2015 [cited by applicant]
US 9039749B2 · Shrivastava et al. · 2015 [cited by applicant]
US 9113936B2 · Palmer et al. · 2015 [cited by applicant]
US 9119656B2 · Bose et al. · 2015 [cited by applicant]
US 9204893B2 · Rizk et al. · 2015 [cited by applicant]
US 9387311B1 · Heilman et al. · 2016 [cited by applicant]
US 9387331B2 · Zhao et al. · 2016 [cited by applicant]
US 9402982B2 · Baert et al. · 2016 [cited by applicant]
US 9433429B2 · Vale et al. · 2016 [cited by applicant]
US 9545505B2 · Heilman et al. · 2017 [cited by applicant]
US 9669195B2 · Heilman et al. · 2017 [cited by applicant]
US 9682216B2 · Teitelbaum · 2017 [cited by applicant]
US 9724501B2 · Heilman et al. · 2017 [cited by applicant]
US 10004621B2 · Kelly · 2018 [cited by applicant]
US 10022251B2 · Teitelbaum · 2018 [cited by applicant]
US 10058686B2 · Heilman et al. · 2018 [cited by applicant]
US 10272230B2 · Malek · 2019 [cited by examiner]
US 10279154B2 · Heilman et al. · 2019 [cited by applicant]
US 10307576B2 · Heilman et al. · 2019 [cited by applicant]
US 10307577B2 · Malek · 2019 [cited by examiner]
US 10625061B2 · Borgesen · 2020 [cited by applicant]
US 10758718B2 · Malek · 2020 [cited by examiner]
US 11951270B2 · Malek · 2024 [cited by examiner]
US 20010041899A1 · Foster · 2001 [cited by applicant]
US 20020183786A1 · Girton · 2002 [cited by applicant]
US 20020188308A1 · Tu et al. · 2002 [cited by applicant]
US 20030040754A1 · Mitchell · 2003 [cited by applicant]
US 20030135147A1 · Rosenberg et al. · 2003 [cited by applicant]
US 20030181938A1 · Roth et al. · 2003 [cited by applicant]
US 20030187495A1 · Cully et al. · 2003 [cited by applicant]
US 20030191520A1 · Pelton · 2003 [cited by applicant]
US 20030220604A1 · Al-Anazi · 2003 [cited by applicant]
US 20030225395A1 · Griffis et al. · 2003 [cited by applicant]
US 20030229366A1 · Reggie et al. · 2003 [cited by applicant]
US 20040059280A1 · Makower et al. · 2004 [cited by applicant]
US 20040073242A1 · Chanduszko · 2004 [cited by applicant]
US 20040087887A1 · Nilsson · 2004 [cited by applicant]
US 20040147871A1 · Burnett · 2004 [cited by applicant]
US 20040153110A1 · Kurz et al. · 2004 [cited by applicant]
US 20040176743A1 · Morris et al. · 2004 [cited by applicant]
US 20040186368A1 · Ramzipoor et al. · 2004 [cited by applicant]
US 20040236309A1 · Yang · 2004 [cited by applicant]
US 20040236409A1 · Pelton et al. · 2004 [cited by applicant]
US 20040254517A1 · Quiroz-Mercado et al. · 2004 [cited by applicant]
US 20040260249A1 · Kulessa · 2004 [cited by applicant]
US 20040260384A1 · Allen · 2004 [cited by applicant]
US 20050033334A1 · Santra et al. · 2005 [cited by applicant]
US 20050119602A1 · Murphy et al. · 2005 [cited by applicant]
US 20050119668A1 · Teague · 2005 [cited by applicant]
US 20050137646A1 · Wallace et al. · 2005 [cited by applicant]
US 20050234509A1 · Widomski et al. · 2005 [cited by applicant]
US 20050245906A1 · Makower et al. · 2005 [cited by applicant]
US 20050251151A1 · Teague · 2005 [cited by applicant]
US 20050256510A1 · Moskowitz et al. · 2005 [cited by applicant]
US 20060015089A1 · Meglin et al. · 2006 [cited by applicant]
US 20060015152A1 · Wallace · 2006 [cited by applicant]
US 20060079915A1 · Chin et al. · 2006 [cited by applicant]
US 20060089704A1 · Douglas · 2006 [cited by applicant]
US 20060173440A1 · Lamson et al. · 2006 [cited by applicant]
US 20060217755A1 · Eversull et al. · 2006 [cited by applicant]
US 20060224101A1 · Glenn · 2006 [cited by applicant]
US 20060224102A1 · Glenn · 2006 [cited by applicant]
US 20060241687A1 · Glaser et al. · 2006 [cited by applicant]
US 20060259063A1 · Bates et al. · 2006 [cited by applicant]
US 20070005125A1 · Berenstein et al. · 2007 [cited by applicant]
US 20070073337A1 · Abbott et al. · 2007 [cited by applicant]
US 20070112291A1 · Borgesen · 2007 [cited by applicant]
US 20070129746A1 · Mische · 2007 [cited by applicant]
US 20070156230A1 · Dugan et al. · 2007 [cited by applicant]
US 20070179426A1 · Selden · 2007 [cited by applicant]
US 20070179428A1 · Kralick et al. · 2007 [cited by applicant]
US 20070208376A1 · Meng · 2007 [cited by applicant]
US 20070225794A1 · Thramann et al. · 2007 [cited by applicant]
US 20070276316A1 · Haffner et al. · 2007 [cited by applicant]
US 20080045863A1 · Bakos · 2008 [cited by applicant]
US 20080057106A1 · Erickson et al. · 2008 [cited by applicant]
US 20080058759A1 · Makower et al. · 2008 [cited by applicant]
US 20080082036A1 · Trescony et al. · 2008 [cited by applicant]
US 20080097398A1 · Mitelberg et al. · 2008 [cited by applicant]
US 20080125805A1 · Mische · 2008 [cited by applicant]
US 20080249458A1 · Yamasaki · 2008 [cited by applicant]
US 20090005645A1 · Frassica et al. · 2009 [cited by applicant]
US 20090017098A1 · Bartolomeo · 2009 [cited by applicant]
US 20090069828A1 · Martin et al. · 2009 [cited by applicant]
US 20090076357A1 · Purdy · 2009 [cited by applicant]
US 20090125093A1 · Hansen · 2009 [cited by applicant]
US 20090171293A1 · Yang et al. · 2009 [cited by applicant]
US 20090287291A1 · Becking et al. · 2009 [cited by applicant]
US 20100010476A1 · Galdonik et al. · 2010 [cited by applicant]
US 20100016887A1 · Inderbitzi · 2010 [cited by applicant]
US 20100063531A1 · Rudakov et al. · 2010 [cited by applicant]
US 20100076366A1 · Henderson, Sr. et al. · 2010 [cited by applicant]
US 20100076404A1 · Ring · 2010 [cited by applicant]
US 20100121357A1 · Flaherty et al. · 2010 [cited by applicant]
US 20100191168A1 · Heilman · 2010 [cited by applicant]
US 20100222732A1 · Sevrain · 2010 [cited by examiner]
US 20110082385A1 · Diaz et al. · 2011 [cited by applicant]
US 20110319917A1 · Ferrera et al. · 2011 [cited by applicant]
US 20120130467A1 · Selden et al. · 2012 [cited by applicant]
US 20120130468A1 · Khosravi et al. · 2012 [cited by applicant]
US 20120172844A1 · Mullen · 2012 [cited by applicant]
US 20130035628A1 · Garrison et al. · 2013 [cited by applicant]
US 20130144328A1 · Weber et al. · 2013 [cited by applicant]
US 20130178828A1 · Takagi et al. · 2013 [cited by applicant]
US 20140005586A1 · Feinstein · 2014 [cited by applicant]
US 20140052047A1 · Wilson · 2014 [cited by applicant]
US 20140052160A1 · Singh et al. · 2014 [cited by applicant]
US 20140128905A1 · Molaei · 2014 [cited by applicant]
US 20140180098A1 · Flaherty et al. · 2014 [cited by applicant]
US 20140180222A1 · Flaherty et al. · 2014 [cited by applicant]
US 20140236207A1 · Makower et al. · 2014 [cited by applicant]
US 20140276342A1 · Stone et al. · 2014 [cited by applicant]
US 20140277079A1 · Vale et al. · 2014 [cited by applicant]
US 20140288414A1 · Makower et al. · 2014 [cited by applicant]
US 20140336559A1 · Heilman et al. · 2014 [cited by applicant]
US 20150196741A1 · Heilman et al. · 2015 [cited by applicant]
US 20150201303A1 · Ji et al. · 2015 [cited by applicant]
US 20150209058A1 · Ferrera et al. · 2015 [cited by applicant]
US 20150223908A1 · Westerfeld et al. · 2015 [cited by applicant]
US 20150258260A1 · Tuseth · 2015 [cited by applicant]
US 20150305756A1 · Rosenbluth et al. · 2015 [cited by applicant]
US 20160136398A1 · Heilman · 2016 [cited by examiner]
US 20160143756A1 · Rezac et al. · 2016 [cited by applicant]
US 20160287276A1 · Cox et al. · 2016 [cited by applicant]
US 20170050000A1 · Randall · 2017 [cited by applicant]
US 20180015267A1 · Heilman et al. · 2018 [cited by applicant]
US 20180126132A1 · Heilman et al. · 2018 [cited by applicant]
US 20190021750A1 · Heilman et al. · 2019 [cited by applicant]
US 20210220135A1 · Kovalsky et al. · 2021 [cited by applicant]
CN 189564 · 2007 [cited by applicant]
CN 1895694 · 2007 [cited by applicant]
EP 0964636 · 1999 [cited by applicant]
EP 1047341 · 2000 [cited by applicant]
EP 1067869 · 2001 [cited by applicant]
EP 1067874 · 2001 [cited by applicant]
EP 1082070 · 2001 [cited by applicant]
EP 1171183 · 2002 [cited by applicant]
EP 1253859 · 2002 [cited by applicant]
EP 1359967 · 2003 [cited by applicant]
EP 1377335 · 2004 [cited by applicant]
EP 1496956 · 2005 [cited by applicant]
EP 1839602B1 · 2009 [cited by applicant]
EP 1854499 · 2009 [cited by applicant]
EP 2589344 · 2013 [cited by applicant]
EP 1981413 · 2014 [cited by applicant]
GB 2089215 · 1982 [cited by applicant]
JP 2006289086 · 2011 [cited by applicant]
WO WO1998016161 · 1998 [cited by applicant]
WO WO2002022028 · 2002 [cited by applicant]
WO WO2006080113 · 2006 [cited by applicant]
WO WO2007115314 · 2007 [cited by applicant]
WO WO2009014723 · 2009 [cited by applicant]
WO WO2009036039 · 2009 [cited by applicant]
WO WO2009088783 · 2009 [cited by applicant]
WO WO2009126935 · 2009 [cited by applicant]
WO WO2011011787 · 2011 [cited by applicant]
WO WO2012009518 · 2012 [cited by applicant]
WO WO2012158152 · 2012 [cited by applicant]
WO WO2013034602 · 2013 [cited by applicant]
WO WO2014165754 · 2014 [cited by applicant]
WO WO2015108917 · 2015 [cited by applicant]
WO WO2016070147 · 2016 [cited by applicant]
WO WO2016070147A1 · 2016 [cited by applicant]
WO WO201707554 · 2017 [cited by applicant]
WO WO2017117427 · 2017 [cited by applicant]
WO WO2018005621 · 2018 [cited by applicant]
WO WO2018071600 · 2018 [cited by applicant]
WO WO2018160966 · 2018 [cited by applicant]
Extended European Search Report for EP Patent Appln. No. 23197404.9 dated Jan. 16, 2024. [cited by applicant]
Extended European Search Report fot EP Patent Appln. No. 20189096.9 dated Sep. 11, 2020. [cited by applicant]
Foreign Office Action for Japanese Patent Application No. 2019-116178 dated Sep. 28, 2020 (translated). [cited by applicant]
Non-Final Office Action for the U.S. Appl. No. 16/976,057 dated Nov. 16, 2020. [cited by applicant]
PCT International Search Report and Written Opinion for International Application No. PCT/2015/011317, Applicant Tufts Medical Center, Inc., Forms PCT/ISA/210, 220, and 237, dated Mar. 26, 2015 (15 pages). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/179,622, dated May 13, 2015 (13 pages). [cited by applicant]
PCT Notification of Transmittal of the International Search Report and Written Opinion, mailed Feb. 17, 2016, for PCT/US2015/058505, Applicant CereVasc, LLC., international filing date Oct. 30, 2015 (16 pages). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 14/596,335, dated Jul. 7, 2016 (16 pages). [cited by applicant]
PCT International Search Report and Written Opinion for International Appln. No. PCTIUS2016/069280, applicant Cerevasc, LLC, dated Mar. 27, 2017 (80 pages). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/294,000, dated Feb. 16, 2017 (26 pages). [cited by applicant]
Final Office Action for U.S. Appl. No. 14/596,335, dated Oct. 26, 2016 (19 pages). [cited by applicant]
Interview Summary for U.S. Appl. No. 14/596,335, dated Oct. 11, 2016 (3 pages). [cited by applicant]
PCT Notification of Transmittal of the International Search Report and Written Opinion of the I.S.A. for PCT/US2016/0595952, mailed Jan. 20, 2017, 14 pages. [cited by applicant]
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2017/056227, Applicant Cerevasc, LLC, Forms PCT/ISA/210, 220, and 237, dated Mar. 29, 2018 (24 pages). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/862,120, dated Apr. 19, 2018. [cited by applicant]
Amendment Response to Office Action for U.S. Appl. No. 15/862,120 dated May 1, 2018. [cited by applicant]
Supplemental Amendment for U.S. Appl. No. 15/862,120 dated May 7, 2018. [cited by applicant]
PCT Invitation to Pay Additional Fees for International Appln. No. PCT/US2018/020667, dated May 29, 2018 (17 pages). [cited by applicant]
PCT International Search Report and Written Opinion for International Appln. No. PCT/US2018/020667, dated Aug. 1, 2018 (21 pages). [cited by applicant]
Examination Report mailed Jan. 25, 2019 for EP Appln. No. 15791220.5. [cited by applicant]
Non-Final Office Action mailed Nov. 6, 2018 for U.S. Appl. No. 15/668,657. [cited by applicant]
Response to Non Final Office Action filed Nov. 14, 2018 for U.S. Appl. No. 15/668,657. [cited by applicant]
Notice of Allowance mailed Dec. 14, 2018 for U.S. Appl. No. 15/668,657. [cited by applicant]
Notice of Allowance mailed Dec. 14, 2018 for U.S. Appl. No. 15/745,961. [cited by applicant]
Non-final office action mailed Mar. 21, 2019 for U.S. Appl. No. 16/212,511. [cited by applicant]
Amendment Response to Office Action for U.S. Appl. No. 16/212,547 dated Mar. 4, 2019. [cited by applicant]
Notice of Allowance mailed Apr. 17, 2019 for U.S. Appl. No. 16/212,511. [cited by applicant]
Notice of Rejection for JP International Patent Appln. No. 2017-542811 dated Nov. 13, 2018. [cited by applicant]
Office Action dated Mar. 5, 2019 for Japanese Patent Appln. No. 2017-542811, with English translation provided by Foreign Associate. [cited by applicant]
Notice of Allowance mailed Apr. 9, 2019 for U.S. Appl. No. 16/212,547. [cited by applicant]
PCT Invitation to Pay Additional Fees for International Appln. No. PCT/US2019/021471, dated Jun. 28, 2019 (10 pages). [cited by applicant]
PCT International Search Report and Written Opinion mailed Aug. 20, 2019 for PCT Appln. No. PCT/US2019/021471, 17 pages. [cited by applicant]
Office action and search report mailed Jul. 29, 2019 for Chinese Application No. 2015800588073, in Chinese with English translation provided by foreign associate. [cited by applicant]
Response to Examination Report filed Jun. 4, 2019 for EP Appln. No. 15791220.5. [cited by applicant]
Response to Foreign Office Action filed Jun. 24, 2019 for JP Patent Appln. No. 2017-542811. [cited by applicant]
PCT Invitation to Pay Additional Fees mailed Jan. 5, 2018 for PCT/US2017/056227, Applicant Cerevasc, LLC, 17 pages. [cited by applicant]
Response to Office action filed Oct. 29, 2019 for Chinese Application No. 2015800588073. [cited by applicant]
EPO communication Rule 71(3) allowance mailed Nov. 7, 2019 for European patent application No. 15791220.5. [cited by applicant]
Foreign OA for JP Patent Appln. No. 2019-116178 dated Jun. 30, 2021 (with attached machine translation). [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/337,346 dated Mar. 15, 2022. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/337,346 dated Oct. 3, 2022. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/759,779 dated Sep. 25, 2025. [cited by applicant]